-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q2 2024 to Q2 2025.
- Neuphoria Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $26,139,160, a 5.6% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)